Wound Heal Clinical Trial
Official title:
The Difference in Wound Size Reduction Comparing Two Frequently Used Wound Dressings in Everyday Care - a Randomized Controlled Trail
Chronic wounds (CW) such as leg or foot ulcers are slow healing wounds. They have a high
recurrence rate and are associated with pain, infection, smell and exudate. The signs and
symptoms of a chronic wounds are not only a burden on those who are affected by it but also
on the health care system and society in general. With a prevalence of 1% in the general
population, the prevalence rises to 3% in the over 80-age group. Current therapeutic
approaches are multifaceted and focus on improving wound healing and preventing recurrences.
Advanced wound dressings, especially super absorbent dressings are an important part of the
wound care. Heavy wound exudate, if unabsorbed, may damage surrounding healthy skin and thus
delay wound healing and contribute to maceration and excoriation regimen as CW may deliver
excessive amounts of exudate followed by maldour. Maldodourous wounds can have a profoundly
negative impact on the quality of life of the patient and of their carers causing feelings of
guilt repulsion and leading to social isolation and depression. Therefore, it is important to
use effective advanced wound dressings that are capable of managing wound exudate and with
that promote wound healing. Currently the standard approches to managing exudate and wound
odour are the use of hydrocellular foam dressing with silver or absorbent dressings like of a
sterile polyacrylate wound pad with activated carbon cloth treatment. However, there is no
evidence demonstrating whether there is adifference in wound size as an indicator of wound
healing when comparing the application of a sterile polyacrylate wound pad with activated
carbon clothtreatment to a standard non-adhesive hydrocellular foam dressing with silver
treatment in a randomised controlled trail.
A randomized controlled trail with 90 participants in one wound care outpatient clinic is
proposed.
Data will be analysed using SPSS version 23. Univariate and bivariate analysis will be
conducted according to the data level and distribution.
This research project is designed to compare two wound dressings in everyday care. Since the
cost of leg ulcers to individuals, the economy, and society is high, the evaluation of wound
care dressings that leads to a reduction of wound size and promote wound healing are
important for the individuals affected, their families, society at large and the health care
system.
Chronic wounds (CW) are poorly healing wounds (Persoon et al., 2004). Chronic leg (LU) and
foot ulcers (DU) occur in many adults with vascular disease or diabetes and are attributed to
chronic venous insufficiency, arterial disease, prolonged pressure, or neuropathy (Frykberg &
Banks, 2015). Epidemiological data from industrialised countries including the United States
of America and Scandinavian countries have shown that the prevalence of leg ulcers in the
general population is 1%; while it is 3% in people over 80 years of age (Posnett, Gottrup,
Lundgren, & Saal, 2009). If these findings are applied to the Swiss context then there are an
estimated 80'000 to 90'000 VLU sufferers of which 8,000 persons are in the above-80
population segment (above 80 year population in Switzerland: 391,000 ) (Swiss Federal
Statistical Office, 2016b). These ulcers last on average 12 to 13 months, recur in up to 60%
to 70% of patients, can lead to loss of function and decreased quality of life, and are a
significant cause of morbidity (Frykberg & Banks, 2015).
Predominantly a condition of the elderly, chronic wounds are becoming more prevalent and more
difficult to treat and are associated with high treatment costs. The care for such conditions
has been an estimated 2% to 3% of all health expenditures in developed countries (Posnett et
al., 2009). With a Swiss health budget of 80 billion Swiss francs in 2016, this would
translate into an annual cost up to 2.4 billion Swiss francs (Swiss Federal Statistical
Office, 2016a).
.The care of chronic wounds has become its own specialty. The therapeutic approach to the
management of CW is a multifaceted approach targeting the management of risk factors
associated with healing rate and recurrence. Evidence showed the healing rate within a
chronic wound is reported to be between 0.1 cm2 and 1cm2 per week independent of the
wound-type (Hussain, 2015). The healing rate is mostly associated of the management of
bacteria that is amongst other things manifested in wound odour and the used wound dressing
and its absorption of wound exudate(Probst, 2015).
Wound odour is not attributed to any one particular source but is thought to be caused by a
combination of bacteria including aerobic and anaerobic species, necrotic tissue, poorly
vascularized tissue and light levels of exudate (Gethin, Grocott, Probst, & Clarke, 2014).
Malodour due to wounds can have a profoundly negative impact on the quality of life of the
patient and of their carers causing feelings of guilt repulsion and leading to social
isolation and depression (Gethin et al., 2014).
Wound exudate is a normal part of the wound healing process in any kind of wound. In general,
the quantity of exudate produced decreases as the wound heals and progresses towards wound
closure (Probst & Huljev, 2013). Exudate is particularly noticeable during the inflammatory
and proliferative phases of healing because it provides nutrients as an energy source for
metabolizing cells and plays a role in regulating the moisture level in the local wound
environment (Coleridge-Smith, Lok, & Ramelet, 2005). This is the case in all chronic wounds.
Managing a wound with a high level of exudate is one of the most commonly cited clinical
problems not only in LU but also in DU or pressure ulcers (Chamanga, 2015; Probst, 2015;
Tickle, 2015). High levels of exudate are challenging in terms of the selection of wound
dressing products capable of handling the fluid levels and also the prevention of damage to
the surrounding healthy skin (Tickle, 2015). Leakage of exudate through the dressing not only
increases the risk of maceration or/ and cross-infection, it may also be distressing for the
patient because of soiling of clothing and bedding and possible malodor (Probst, Arber, &
Faithfull, 2013b).Due to unabsorbed heavy exudate, healing is delayed and surrounding skin
can be badly damaged due to maceration and excoriation (Chamanga, 2015). Additionally, the
psychological effects of coping with a chronic wound on a day to day basis should not be
underestimated (Probst, Arber, & Faithfull, 2013a). For health services, the management of
excess exudate presents considerable costs in terms of health professionals' time spent on
more frequent visits to change dressings and costs for dressings and associated preventive
measures such as skin protection (Probst, 2015). Therefore, the use of effective advanced
wound dressings that manage exudate are an important aspect of wound therapy. There are many
advanced wound dressings on the market absorbing excessive amounts of exudate. Currently the
standard approaches to managing exudate and the presence of high bacteria load are dressings
with silver such as the use of hydrocellular foam dressing with silver (non-adhesive or
adhesive) or absorbent dressings. However, there is no evidence demonstrating the difference
of wound size applying a sterile polyacrylate wound pad with activated carbon cloth treatment
in comparison to a standard non -adhesive hydrocellular foam dressing with silver treatment.
This research project is designed to compare two wound dressings in everyday care. Through
this comparison the effective amount of wound exudate in the population of LU and DU can be
measured. Since the cost of leg ulcers to individuals, the economy, and society is high, the
evaluation of wound care dressings that leads to a reduction of wound size and promote wound
healing are important for the individuals affected, for society at large and the health care
system.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05023135 -
DeepView SnapShot Portable (DV-SSP): Device Training Study
|
||
Recruiting |
NCT03459547 -
Soft Peri-implant Tissue Around Different Abutment Materials
|
N/A | |
Recruiting |
NCT05608187 -
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
|
Phase 2 | |
Active, not recruiting |
NCT03649308 -
Negative Pressure Wound Therapy Compared to Traditional Care After Skin Grafting
|
N/A | |
Recruiting |
NCT04596124 -
Effectiveness and Tolerability of Fitostimoline Plus Cream and Gauze vs Connettivina Bio Plus Cream and Gauze
|
N/A | |
Completed |
NCT03285542 -
Prospective Randomized Trial of Dermabond Prineo in Total Knee Arthroplasty
|
N/A | |
Recruiting |
NCT05689775 -
Reconstruction After Abdominoperineal Resection With Robot-assisted Harvest of VRAM Flap
|
||
Recruiting |
NCT05474911 -
PILONIDAL SINUS: CONVENTIONAL CARE VERSUS NEGATIVE PRESSURE THERAPY.
|
N/A | |
Recruiting |
NCT04849143 -
The Effectiveness of Stingless Bee Honey (Kelulut Honey) Versus Gel in Diabetic Wound Bed Preparation
|
N/A | |
Recruiting |
NCT05169814 -
Micro/Nanobubbles (MNBs) for Treatment of Acute and Chronic Wounds
|
Early Phase 1 | |
Completed |
NCT04545476 -
Enhanced Secondary Intention Healing vs. Standard Secondary Intention Healing in Mohs Surgical Defects on the Head and Distal Lower Extremities
|
N/A | |
Completed |
NCT06020157 -
Comparison of Simple and Continuous Suture Techniques in Oral Surgery
|
N/A | |
Recruiting |
NCT05133570 -
Study Evaluating the Effectiveness of Treatment With Vista Care®, in Arterial Ulcers of the Lower Extremities
|
||
Recruiting |
NCT04901325 -
Baricitinib in the Treatment of Adults With Pyoderma Gangrenosum (PG)
|
Phase 2 | |
Withdrawn |
NCT03668665 -
Influencing Wound Healing Through the Application of Hyaluronic Acid With Perfluorodecalin and Physalis Angulata Extract After Split Skin Removal From the Thigh - A Study in "Split Wound Design"
|
Phase 3 | |
Completed |
NCT03703479 -
Effect of A-PRF After Removal of Wisdom Teeth
|
N/A | |
Recruiting |
NCT03204851 -
Microlyte Dressing in the Management of Wounds
|
N/A | |
Recruiting |
NCT06117436 -
Impact of Cilostazol Versus Cilostazol and Selenium Combination on the Healing of Diabetic Foot Ulcer Patients
|
Phase 2/Phase 3 | |
Completed |
NCT05618912 -
Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment
|
N/A | |
Completed |
NCT05252260 -
Comparison of Diode Laser-Assisted Vestibuloplasty And Conventional Vestibuloplasty
|
N/A |